In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Hemostasis tests help screen and identify patients with hemostatic defects. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hemostasis tests market in Switzerland. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the hemostasis tests market in Switzerland was Abbott Laboratories followed by bioMerieux, Bio-Rad Laboratories, Danaher, Diagnostica Stago, F. Hoffmann-La Roche, Quidelortho, Siemens and Werfen Life.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Hemostasis tests includes the sub-segments Prothrombin time tests, Prothrombin time (PT) POC test, Prothrombin time laboratory tests, activated partial thromboplastin time (aPTT or PTT) tests, Activated partial thromboplastin time (aPTT) POC tests, Activated partial thromboplastin time (aPTT or PTT) laboratory tests, D-dimer tests, D-dimer POC test, and D-dimer laboratory tests. Laboratory tests: Any tests that require transporting of patient samples to a laboratory, including those with rapid turnaround times, are defined as laboratory or lab-based tests. Point Of Care Tests (POC): Point of Care Testing (POC) is defined as medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care. POC is typically performed by non-laboratory personnel and the results are used for clinical decision making. POC has a range of complexity and procedures that vary from manual methodologies to automated analyzers. POC devices are often ‘handheld’ or may be small portable analyzers. In the Hemostasis tests market, POC tests often include devices used in physician's offices and for at-home monitoring.
The hemostasis tests market in Switzerland can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size hemostasis tests in Switzerland, buy the report here.